FDA Approves Sotagliflozin for Treatment of Heart Failure
NexoBrid for Eschar Removal in Thermal Burns
Anacaulase-bcdb improves current standard of care for deep partial thickness and/or full thickness thermal burns.
FDA Approves Terlipressin for the Management of HRS-1
Approval followed resubmission of data from the phase 3 CONFIRM trial to the agency.
Vivjoa Approved for Recurrent Vulvovaginal Candidiasis
Oteseconazole is a treatment option for those living with a previously unmet medical need.
Molnupiravir: Oral Antiviral for the Treatment of COVID-19
Molnupiravir is an oral antiviral for the treatment of mild to moderate COVID-19 in adults at high risk of severe disease.
Paxlovid: Oral Antiviral for the Treatment of COVID-19
Pfizer received an emergency use authorization (EUA) for Paxlovid, an oral pill for the treatment of mild to moderate COVID-19 in certain adult and pediatric populations.
New Drug Review: Atogepant FDA-Approved for Migraine Treatment
On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.
2 Commerce Drive Cranbury, NJ 08512